Contemporary OBGYN week in review: embryo transfer, fentanyl, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OBGYN week in review: embryo transfer, fentanyl, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, October 30 - Friday, November 3, 2023), and click each link to read and watch anything you may have missed.
1.) Advantages of delaying embryo transfer after pregnancy loss
In a recent study, women with an interpregnancy interval under 3 months, more often had worse pregnancy outcomes compared to those with an interval of 3 to under 6 months or of 6 to 12 months.
Click here for the full article.
2.) Prenatal fentanyl exposure and a novel syndrome
In a recent study, physical abnormalities were seen among children born from pregnancies complicated by fentanyl.
Click here for the full article.
3.) Utility of pelvic ultrasound imaging in diagnosing endometriosis
Findings and significance for gynecologic surgeons.
Click here for the full article.
4.) Artificial intelligence for embryo evaluation
In a recent study, models for embryo evaluation using artificial intelligence had strong accuracy.
5.) Misoprostol alone effective for abortion
In a recent story, a completed abortion was reported in 98.6% of patients taking a misoprostol alone regimen.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
